[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100599437":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":19,"locations":27,"responsibleParty":40,"collaborators":10,"id":42,"slug":10,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":10,"eligibilityCriteria":47,"healthyVolunteers":43,"sex":48,"minAge":49,"maxAge":10,"enrollmentInfo":50,"targetDuration":10,"studyType":53,"phases":10,"briefSummary":54,"conditions":55,"keywords":58,"overallStatus":30,"whyStopped":10,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Wuerzburg University Hospital","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Known patients",null,"Patients, who are already known and had regular visits in the outpatient rheumatology department of the Würzburg university hospital. These patients already receive immunosuppressive therapy.",{"label":13,"type":10,"description":14,"interventionNames":10},"New patients","Patients who have not yet been treated by the outpatient rheumatology department of the Würzburg university hospital, preferably but not limited to immunosuppressive therapy-naive patients.",[16],{"name":17,"affiliation":5,"role":18},"Michael Gernert","PRINCIPAL_INVESTIGATOR",[20,24],{"name":17,"role":21,"phone":22,"phoneExt":10,"email":23},"CONTACT","+4993120140100","gernert_m1@ukw.de",{"name":25,"role":21,"phone":22,"phoneExt":10,"email":26},"Hannah Labinsky","Labinsky_h@ukw.de",[28],{"facility":29,"status":30,"city":31,"state":10,"zip":10,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":10},"Universitätsklinikum Würzburg","RECRUITING","Würzburg","Germany","DE",{"type":35,"coordinates":36},"Point",[37,38],9.95121,49.79391,{"lat":38,"lon":37},{"type":41,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100599437",false,"NCT07084480","Giant Cell Arteritis - Ways to Precision Medicine","Riesenzellarteriitis - Wege Zur \"Precision Medicine\"","Inclusion Criteria:\n\n* Age greater or similar to 18 years\n* Primary diagnosis of GCA or PMR\n\nExclusion Criteria:\n\n* Age under 18 years\n* lack of capacity to consent","ALL","18 Years",{"count":51,"type":52},400,"ESTIMATED","OBSERVATIONAL","Long-term follow-up of aortal adverse events, as well as glucocortioid-associated adverse events in patients with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).",[56,57],"Giant Cell Arteritis","Polymyalgia Rheumatic (PMR)",[59,60,61,62,63],"non-interventional cohort study","aortic dilatation","innate lymhoid cells","optic coherence tomography","MRI","2025-12-15",{"date":66,"type":67},"2025-12-22","ACTUAL",{"date":69,"type":67},"2025-11-14",{"date":71,"type":52},"2033-07-31",{"name":5,"class":6},1]